IARC Monographs on the Evaluation of Carcinogenic Risks to Humans,
Volume 64: Human Papillomaviruses . Lyon, France: International Agency for Research on Cancer; 1995.
Koutsky LA, Holmes KK, Critchlow CW.
et al. A cohort study of the risk of cervical intraepithelial neoplasia grade
2 or 3 in relation to papillomavirus infection. N Engl J Med.1992;327:1272-1278.
Ho GYF, Bierman R, Beardsley L.
et al. Natural history of cervicovaginal papillomavirus infection in young
women. N Engl J Med.1998;338:423-428.
Moscicki AB, Shiboski S, Broering J.
et al. The natural history of human papillomavirus infection as measured by
repeated DNA testing in adolescent and young women. J Pediatr.1998;132:277-284.
Liaw K, Glass AG, Manos MM.
et al. Detection of human papillomavirus DNA in cytologically normal women
and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst.1999;91:954-960.
Wallin KL, Wiklund F, Ångström T.
et al. Type-specific persistence of human papillomavirus DNA before the development
of invasive cervical cancer. N Engl J Med.1999;341:1633-1638.
Ylitalo N, Sørensen P, Josefsson AM.
et al. Consistent high viral load of human papillomavirus 16 and risk of cervical
carcinoma in situ: a nested case-control study. Lancet.2000;355:2194-2198.
Moscicki AB, Hills N, Shiboski S.
et al. Risks for incident human papillomavirus infection and low-grade squamous
intraepithelial lesion development in young females. JAMA.2001;285:2995-3002.
Woodman CB, Collins S, Winter H.
et al. Natural history of cervical human papillomavirus infection in young
women: a longitudinal cohort study. Lancet.2001;357:1831-1836.
Ho GY, Burk RD, Klein S.
et al. Persistent genital human papillomavirus infection as a risk factor
for persistent cervical dysplasia. J Natl Cancer Inst.1995;87:1365-1371.
Franco EL, Villa L, Rohan T.
et al. Design and methods of the Ludwig-McGill longitudinal study of the natural
history of human papillomavirus infection and cervical neoplasia in Brazil. Rev Panam Salud Publica.1999;6:223-233.
The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses.
Developed and approved at the National Cancer Institute Workshop, Bethesda,
Maryland, USA, December 12-13, 1988. Acta Cytol.1989;33:567-574.
Bauer HM, Ting Y, Greer CE.
et al. Genital human papillomavirus infection in female university students
as determined by a PCR-based method. JAMA.1991;265:472-477.
Hildesheim A, Schiffman MH, Gravitt PE.
et al. Persistence of type-specific human papillomavirus infection among cytologically
normal women. J Infect Dis.1994;169:235-240.
Bernard HU, Chan SY, Manos MM.
et al. Identification and assessment of known and novel human papillomaviruses
by polymerase chain reaction amplification, restriction fragment length polymorphisms,
nucleotide sequence, and phylogenetic algorithms. J Infect Dis.1994;170:1077-1085.
Bauer HM, Hildesheim A, Schiffman MH.
et al. Determinants of genital human papillomavirus infection in low-risk
women in Portland, Oregon. Sex Transm Dis.1993;20:274-278.
Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary
cause of cervical cancer. J Natl Cancer Inst.1999;91:506-511.
Franco EL, Villa LL, Rahal P.
et al. Molecular variant analysis as an epidemiological tool to study persistence
of cervical human papillomavirus infection. J Natl Cancer Inst.1994;86:1558-1559.
Villa LL, Sichero L, Rahal P, Ruiz A. Molecular variants of human papillomavirus types 16 and 18 preferentially
associated with cervical neoplasia. J Gen Virol.2000;81:2959-2968.
Ellerbrock TV, Chiasson MA, Bush TJ.
et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected
Londesborough P, Ho L, Terry G.
et al. Human papillomavirus genotype as a predictor of persistence and development
of high-grade lesions in women with minor cervical abnormalities. Int J Cancer.1996;69:364-368.
Kataja V, Syrjänen K, Mäntyjärvi R.
et al. Prospective follow-up of cervical HPV infections: life table analysis
of histological, cytological and colposcopic data. Eur J Epidemiol.1989;5:1-7.